Vimarsana
Biggest News Aggregation in the World

Page 42 - Yi Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yi Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yi Chen Today - Breaking & Trending Today

夏宇童大方貼近「磨鼻子」 孫協志新節目收視開紅盤 - 娛樂 - Vimarsana News

夏宇童大方貼近「磨鼻子」 孫協志新節目收視開紅盤 - 娛樂

孫協志和王仁甫在主持新節目《明星許願池》中,不計形象「男扮女裝」,孫協志飾演全天下最難搞的婆婆,與王仁甫腿開開熱舞,尤其王仁甫長裙拉到大腿讓「毛腿大開」,搞笑功力一流,孫協志更與夏宇童大方放閃「磨鼻子

Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript - Vimarsana News

Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript

INO earnings call for the period ending June 30, 2021.

Source: fool.com
Highlights From N.Y.C. Mayoral Primary: Eric Adams Declares Victory - Vimarsana News

Highlights From N.Y.C. Mayoral Primary: Eric Adams Declares Victory

Highlights From N.Y.C. Mayoral Primary: Eric Adams Declares Victory Last Updated July 6, 2021, 11:06 p.m. ETJuly 6, 2021, 11:06 p.m. ET The Associated Press called the Democratic primary for Mr. Adams, who solidified his lead over Kathryn Garcia and Maya Wiley after the New York City Board of Elections released additional results Tuesday evening. Here’s what you need to know: Eric Adams, the Brooklyn borough president and a former police captain, ran on a promise to improve public safety.Credit...James Estrin/The New York Times Eric Adams, the Brooklyn borough president and a former police ...

Nicox: Half-year liquidity contract statement with Kepler - Vimarsana News

Nicox: Half-year liquidity contract statement with Kepler

-        Number of executions on sell side on semester: 609 -        Traded volume on buy side on semester: 457,955 shares for € 1,916,480.01 -        Traded volume on sell side on semester: 310,810 shares for € 1,312,111.94 •        the following resources appeared on the liquidity account when the activity started: -        0 shares -        € 500,000.00 The liquidity agreement complies with AMF Decision n° 2018-01 dated 2nd July 2018, introducing liquidity agreements on equity securities as permitted market practice. About Nicox Nico...

Nicox to Receive $2 Million from Ocumension Therapeutics as - Vimarsana News

Nicox to Receive $2 Million from Ocumension Therapeutics as

® Agreement Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it has amended its March 2019 license agreement with Ocumension Therapeutics, under which Ocumension has exclusive rights to develop and commercialize ZERVIATE ® (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. Under the amended agreement, Ocumension will immediately pay Nicox $2 million in full advance payment of the future development and regulatory milestones for the product. Amendments were mad...